The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcus Biosciences Inc shares valued at $53,910 were sold by Goeltz II Robert C. on Dec 31 ’24. At $15.00 per share, Goeltz II Robert C. sold 3,594 shares. The insider’s holdings dropped to 60,138 shares worth approximately $0.67 million following the completion of this transaction.
Also, Goeltz II Robert C. purchased 3,594 shares, netting a total of over 53,910 in proceeds.
Before that, Azoy Alexander had sold 201 shares from its account. In a trade valued at $3,079, the Chief Accounting Officer traded Arcus Biosciences Inc shares for $15.32 each. Upon closing the transaction, the insider’s holdings decreased to 201 shares, worth approximately $0.21 million.
As published in their initiating research note from H.C. Wainwright on October 21, 2024, Arcus Biosciences Inc [RCUS] has been a Neutral and the price target has been revised to $20. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in early October. As of November 18, 2022, BofA Securities has initiated its “Neutral” rating for RCUS. Earlier on October 11, 2022, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for RCUS stock.
Analyzing RCUS Stock Performance
During the last five days, there has been a drop of approximately -7.27%. Over the course of the year, Arcus Biosciences Inc shares have dropped approximately -25.45%. Shares of the company reached a 52-week high of $15.61 on 01/07/25 and a 52-week low of $10.65 on 02/18/25. A 50-day SMA is recorded $14.43, while a 200-day SMA reached $15.64. Nevertheless, trading volume fell to 4.73 million shares from 4.66 million shares the previous day.
Support And Resistance Levels for Arcus Biosciences Inc (RCUS)
According to the 24-hour chart, there is a support level at 10.79, which, if violated, would cause prices to drop to 10.49. In the upper region, resistance lies at 11.55. The next price resistance is at 12.00. RSI (Relative Strength Index) is 32.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.87, which suggests the price will decrease in the coming days. Percent R is at 85.83%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
